Literature DB >> 8350638

Herpes zoster-associated meningoencephalitis in patients with systemic cancer.

B A Hughes1, D W Kimmel, A J Aksamit.   

Abstract

We reviewed the experience at the Mayo Clinic with neurologic complications related to herpes zoster in patients with systemic cancer. Aside from pain, the most common neurologic complication was zoster-associated meningoencephalitis, which occurred in 9 of 1,125 patients. In these nine patients, the most common underlying malignant lesions were chronic lymphocytic leukemia and lymphoma. All patients in whom meningoencephalitis developed had trigeminal zoster or disseminated zoster. The primary neurologic symptoms were headache, confusion, and somnolence. Nuchal rigidity and fever were uncommon. The response to treatment with acyclovir was generally favorable.

Entities:  

Mesh:

Year:  1993        PMID: 8350638     DOI: 10.1016/s0025-6196(12)60600-4

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

Review 1.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

2.  Case files of the Harvard medical toxicology fellowship: valacyclovir neurotoxicity and unintentional overdose.

Authors:  Colin Huguenel; Diana Felton; Rebecca Bruccoleri; Steven Salhanick
Journal:  J Med Toxicol       Date:  2015-03

Review 3.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

Review 4.  Cognitive outcome in acute sporadic encephalitis.

Authors:  L Hokkanen; J Launes
Journal:  Neuropsychol Rev       Date:  2000-09       Impact factor: 6.940

5.  Subcortical type cognitive impairment in herpes zoster encephalitis.

Authors:  L Hokkanen; J Launes; E Poutiainen; L Valanne; O Salonen; J Sirén; M Iivanainen
Journal:  J Neurol       Date:  1997-04       Impact factor: 6.682

6.  Valacyclovir-induced Neurotoxicity in a Patient with a Preserved Renal Function.

Authors:  Takashi Yoshimura; Tatsuya Kawasaki; Ayumi Shirota; Masashi Saeki; Yuki Okada; Hiroshi Okada
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

7.  Risk Factors for Aseptic Meningitis in Herpes Zoster Patients.

Authors:  Sang-Hoon Kim; Seong-Min Choi; Byeong C Kim; Kang-Ho Choi; Tai-Seung Nam; Joon-Tae Kim; Seung-Han Lee; Man-Seok Park; Seong J Kim
Journal:  Ann Dermatol       Date:  2017-05-11       Impact factor: 1.444

8.  When a Seemingly Harmless Prescription Turns into Toxicity.

Authors:  Zurab Azmaiparashvili; Kevin Bryan Lo; Nawal Habib; Annie Hsieh
Journal:  Case Rep Med       Date:  2018-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.